These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 15177020)

  • 1. E1A signaling to p53 involves the p19(ARF) tumor suppressor.
    de Stanchina E; McCurrach ME; Zindy F; Shieh SY; Ferbeyre G; Samuelson AV; Prives C; Roussel MF; Sherr CJ; Lowe SW
    Genes Dev; 1998 Aug; 12(15):2434-42. PubMed ID: 9694807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal instability at a mutational hotspot in polyoma middle T-antigen affects its ability to activate the ARF-p53 tumor suppressor pathway.
    Rodriguez-Viciana P; Collins CH; Moule MG; Fried M
    Oncogene; 2006 Mar; 25(10):1454-62. PubMed ID: 16261156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Over-Expression of E2F3 Might Serve as Prognostic Marker for Neuroblastoma Patients with Stage 4S Disease.
    Parodi S; Ognibene M; Haupt R; Pezzolo A
    Diagnostics (Basel); 2020 May; 10(5):. PubMed ID: 32429447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of E2F Transcription Factor 3 by microRNA-152 Modulates Gastric Cancer Invasion and Metastasis.
    Shi L; Zhu H; Shen Y; Dou X; Guo H; Wang P; Zhang S; Zhou L; Zou X
    Cancer Manag Res; 2020; 12():1187-1197. PubMed ID: 32110093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F3 upregulation promotes tumor malignancy through the transcriptional activation of HIF-2α in clear cell renal cell carcinoma.
    Gao Y; Li H; Ma X; Fan Y; Ni D; Zhang Y; Huang Q; Liu K; Li X; Wang L; Yao Y; Ai Q; Zhang X
    Oncotarget; 2017 Aug; 8(33):54021-54036. PubMed ID: 28903320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3.
    Ma C; Han J; Dong D; Wang N
    Oncol Res; 2018 Jun; 26(5):765-773. PubMed ID: 28810933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging roles of p53 and other tumour-suppressor genes in immune regulation.
    Muñoz-Fontela C; Mandinova A; Aaronson SA; Lee SW
    Nat Rev Immunol; 2016 Dec; 16(12):741-750. PubMed ID: 27667712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.
    Payne CM; Crowley-Skillicorn C; Bernstein C; Holubec H; Bernstein H
    Clin Exp Gastroenterol; 2011; 4():75-119. PubMed ID: 21753893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
    Heidenblad M; Lindgren D; Jonson T; Liedberg F; Veerla S; Chebil G; Gudjonsson S; Borg A; Månsson W; Höglund M
    BMC Med Genomics; 2008 Jan; 1():3. PubMed ID: 18237450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs.
    Longworth MS; Wilson R; Laimins LA
    EMBO J; 2005 May; 24(10):1821-30. PubMed ID: 15861133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the Arf/p53 tumor surveillance network by E2F.
    Iaquinta PJ; Aslanian A; Lees JA
    Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB: tumor promoter or suppressor?
    Perkins ND
    Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2F3-a novel repressor of the ARF/p53 pathway.
    Ginsberg D
    Dev Cell; 2004 Jun; 6(6):742-3. PubMed ID: 15177020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
    Aslanian A; Iaquinta PJ; Verona R; Lees JA
    Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ARF tumor suppressor: keeping Myc on a leash.
    Gregory MA; Qi Y; Hann SR
    Cell Cycle; 2005 Feb; 4(2):249-52. PubMed ID: 15655352
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.